Nvidia stock saw a massive pullback in Monday's trading, closing out the daily session down 17%. The sell-off worked out to a roughly $600 billion pullback in the GPU leader's market capitalization ...
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, ...
Bicycle Therapeutics' BT8009 offers strong safety and efficacy. Find out why BCYC stock could be a buy, despite recent volatility and awaiting mid-2025 data.